Description

Erythromycin A 6,9-Imino Ether is a key chemical intermediate in the synthesis of advanced macrolide antibiotics. This compound is critical for pharmaceutical manufacturers seeking to develop and produce next-generation antibacterial agents with improved efficacy and stability. It is primarily utilized by R&D laboratories and production facilities in the active pharmaceutical ingredient (API) sector for creating novel semi-synthetic derivatives of erythromycin.

Application

• Pharmaceutical Intermediate: A crucial building block in the synthesis of advanced macrolide antibiotics, such as clarithromycin and other semi-synthetic derivatives.
• Antibacterial Drug Development: Used in research and development for creating new antibiotic candidates with enhanced pharmacokinetic properties.
• API Manufacturing: Serves as a high-purity intermediate in the commercial-scale production of active pharmaceutical ingredients (APIs).
• Chemical Synthesis Research: Employed in academic and industrial laboratories for studying macrolide chemistry and developing novel synthetic pathways.
• Process Chemistry: Integral to optimizing and scaling up manufacturing processes for complex antibiotic molecules.

Basic Information

Product Name	Erythromycin A 6,9-Imino Ether
CAS No.	99290-97-8
Molecular Formula	C37H67NO12
Molecular Weight	717.93 g/mol
Synonyms	6,9-Imino Ether of Erythromycin A; Erythromycin 6,9-9,12-Spiroketal; Erythromycin A 6,9-Ether; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione; Erythronolide A 6,9-Imino Ether
EINECS	Contact for details

Quality Control

Our Erythromycin A 6,9-Imino Ether is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical synthesis. Certificates of Analysis (COA) are available upon request, detailing all relevant specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials and excessive heat.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.